Formulation: A crystalline solid
Pricing updated 2018-11-19. Prices are subject to change without notice.
AB-CHMINACA (Item No. 15434) is an indazole-based synthetic cannabinoid (CB) that is structurally related to AB-FUBINACA (Item No. 14039), a high affinity ligand of the CB1 receptor (Ki = 0.9 nM).1,2 MDMB-CHMICA is an indole-based CB that is structurally similar to AB-CHMINACA by bearing an identical cyclohexyl group, but has a dimethylbutanoate group instead of a methylbutanamide. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.
Warning - this product is not for human or veterinary use.
View our Base Peak Identification Tool
View our Flipbook Identification Tool
View the Cayman Structure Database for chemical structure definitions for many Cayman products
View the Cayman Spectral Library (CSL) for ChemStation-searchable GC-MS spectra of many of Cayman's emerging forensic drug standards
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.
Uchiyama, N., Matsuda, S., Wakana, D., et al. New cannabimimetic indazole derivatives, N-
2. Buchler, I.P., Hayes, M.J., Hedge, S.G., et al. Indazole derivatives PCT/IB2009/000432, 1-283 (2009).